Yes , I would say it has value also . The rhamnose binding protein (RBP) on the cell is targeted by Coramsine to kill the cancer cells . To have this mode of action recognised as unique and protected in the worlds most lucrative biotech market is probably worth a great deal if the drug works , and indications are that it does .
Cheers
SBP
solbec pharmaceuticals limited
grant of us patent, page-2
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)